We thank the financial support from Genome Canada and Genome British Columbia for operations (204PRO) and technology development (214PRO) through the Genome Innovations Network (GIN). We thank the Drug Discovery Platform at the Research Institute of the McGill University Health Center for the use of the MALDI-TOF instrument for filming. H.L. is grateful for support from a postdoctoral fellowship from the National Science and Engineering Research Council of Canada (NSERC). C.H.B is grateful for support from the Leading Edge Endowment Fund (LEEF). C.H.B. is grateful for support from the Segal McGill Chair in Molecular Oncology at McGill University (Montreal, Quebec, Canada). M.X.C. and C.H.B. are grateful for support from the Warren Y. Soper Charitable Trust and the Alvin Segal Family Foundation to the Jewish General Hospital (Montreal, Quebec, Canada).

The amounts of the reagents described below are based on the measurement of 20 patient plasma samples. The protocol presented below follows the guidelines of the University of Victoria&#39;s human research ethics committee.
1. Generation of Ang I in Human Plasma
<ol>
	<li>Thaw plasma samples (&#8805;200 &#181;L) in a room temperature water bath for 5 min, and then put the samples on ice until completely thawed.</li>
	<li>Transfer 200 &#181;L of each plasma sample manually to separate wells o...

<ol>
	<li>Aebersold, R., Mann, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mass+spectrometry-based+proteomics.">Mass spectrometry-based proteomics.</a> Nature. 422 (6928), 198-207 (2003).</li><li>Nicol, G. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Use+of+an+Immunoaffinity-Mass+Spectrometry-based+Approach+for+the+Quantification+of+Protein+Biomarkers+from+Serum+Samples+of+Lung+Cancer+Patients.">Use of an Immunoaffinity-Mass Spectrometry-based Approach for the Quantification of Protein Biomarkers from Serum Samples of Lung Cancer Patients.</a> Mol. &amp; Cell. Proteomics. 7 (10), 1974-1982 (2008).</li><li>Webster, J., Oxley, D., Zanders, E. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Chemical Genomics and Proteomics: Reviews and Protocols. , 227-240 (2012).</li><li>Yergey, A. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=De+novo+sequencing+of+peptides+using+MALDI/TOF-TOF.">De novo sequencing of peptides using MALDI/TOF-TOF.</a> J. Am. Soc. Mass Spectrom. 13 (7), 784-791 (2002).</li><li>Anderson, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Six+decades+searching+for+meaning+in+the+proteome.">Six decades searching for meaning in the proteome.</a> J. Proteomics. 107, 24-30 (2014).</li><li>Landegren, U., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Opportunities+for+Sensitive+Plasma+Proteome+Analysis.">Opportunities for Sensitive Plasma Proteome Analysis.</a> Anal. Chem. 84 (4), 1824-1830 (2012).</li><li>Guo, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Immunoaffinity+Enrichment+and+Mass+Spectrometry+Analysis+of+Protein+Methylation.">Immunoaffinity Enrichment and Mass Spectrometry Analysis of Protein Methylation.</a> Mol. &amp; Cell. Proteomics. 13 (1), 372-387 (2014).</li><li>Florentinus-Mefailoski, A., Soosaipillai, A., Dufresne, J., Diamandis, E. P., Marshall, J. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+enzyme-linked+immuno-mass+spectrometric+assay+with+the+substrate+adenosine+monophosphate.">An enzyme-linked immuno-mass spectrometric assay with the substrate adenosine monophosphate.</a> Anal. Bioanal. Chem. 407 (4), 1119-1130 (2015).</li><li>Fredolini, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Immunocapture+strategies+in+translational+proteomics.">Immunocapture strategies in translational proteomics.</a> Expert Rev Proteomics. 13 (1), 83-98 (2016).</li><li>Tran, J. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Automated+Affinity+Capture+and+On-Tip+Digestion+to+Accurately+Quantitate+in+Vivo+Deamidation+of+Therapeutic+Antibodies.">Automated Affinity Capture and On-Tip Digestion to Accurately Quantitate in Vivo Deamidation of Therapeutic Antibodies.</a> Anal. Chem. , (2016).</li><li>Razavi, M., Leigh Anderson, N., Pope, M. E., Yip, R., Pearson, T. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High+precision+quantification+of+human+plasma+proteins+using+the+automated+SISCAPA+Immuno-MS+workflow.">High precision quantification of human plasma proteins using the automated SISCAPA Immuno-MS workflow.</a> N. Biotechnol. 33 (5 Part A), 494-502 (2016).</li><li>Razavi, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High-Throughput+SISCAPA+Quantitation+of+Peptides+from+Human+Plasma+Digests+by+Ultrafast,+Liquid+Chromatography-Free+Mass+Spectrometry.">High-Throughput SISCAPA Quantitation of Peptides from Human Plasma Digests by Ultrafast, Liquid Chromatography-Free Mass Spectrometry.</a> J. Proteome Res. 11 (12), 5642-5649 (2012).</li><li>Anderson, N. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=SISCAPA+Peptide+Enrichment+on+Magnetic+Beads+Using+an+In-line+Bead+Trap+Device.">SISCAPA Peptide Enrichment on Magnetic Beads Using an In-line Bead Trap Device.</a> Mol. &amp; Cell. Proteomics. 8 (5), 995-1005 (2009).</li><li>Parker, C. E., Pearson, T. W., Anderson, N. L., Borchers, C. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mass-spectrometry-based+clinical+proteomics+-+a+review+and+prospective.">Mass-spectrometry-based clinical proteomics - a review and prospective.</a> The Analyst. 135 (8), 1830-1838 (2010).</li><li>Reid, J. D., Holmes, D. T., Mason, D. R., Shah, B., Borchers, C. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Towards+the+Development+of+an+Immuno+MALDI+(iMALDI)+Mass+Spectrometry+Assay+for+the+Diagnosis+of+Hypertension.">Towards the Development of an Immuno MALDI (iMALDI) Mass Spectrometry Assay for the Diagnosis of Hypertension.</a> J. Am. Soc. Mass Spectrom. 21 (10), 1680-1686 (2010).</li><li>Mason, D. R., Reid, J. D., Camenzind, A. G., Holmes, D. T., Borchers, C. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Duplexed+iMALDI+for+the+detection+of+angiotensin+I+and+angiotensin+II.">Duplexed iMALDI for the detection of angiotensin I and angiotensin II.</a> Methods. 56 (2), 213-222 (2012).</li><li>Camenzind, A. G., vander Gugten, J. G., Popp, R., Holmes, D. T., Borchers, C. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Development+and+evaluation+of+an+immuno-MALDI+(iMALDI)+assay+for+angiotensin+I+and+the+diagnosis+of+secondary+hypertension.">Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension.</a> Clin. Proteomics. 10 (1), 20 (2013).</li><li>Jiang, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Development+of+an+immuno+tandem+mass+spectrometry+(iMALDI)+assay+for+EGFR+diagnosis.">Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis.</a> Proteomics Clin Appl. 1, (2007).</li><li>Jiang, J., Parker, C. E., Fuller, J. R., Kawula, T. H., Borchers, C. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+Immunoaffinity+Tandem+Mass+Spectrometry+(iMALDI)+assay+for+Detection+of+Francisella+tularensis.">An Immunoaffinity Tandem Mass Spectrometry (iMALDI) assay for Detection of Francisella tularensis.</a> Analytica chimica acta. 605 (1), 70-79 (2007).</li><li>Popp, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+automated+assay+for+the+clinical+measurement+of+plasma+renin+activity+by+immuno-MALDI+(iMALDI).">An automated assay for the clinical measurement of plasma renin activity by immuno-MALDI (iMALDI).</a> Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1854 (6), 547-558 (2015).</li><li>Schoenherr, R. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Automated+screening+of+monoclonal+antibodies+for+SISCAPA+assays+using+a+magnetic+bead+processor+and+liquid+chromatography-selected+reaction+monitoring-mass+spectrometry.">Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry.</a> J Immunol Methods. 353 (1-2), 49-61 (2010).</li><li>Borchers, C. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Methods+of+quantitation+and+identification+of+peptides+and+proteins.">Methods of quantitation and identification of peptides and proteins.</a> US patent. , (2010).</li><li>Borchers, C. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Methods+of+quantitation+and+identification+of+peptides+and+proteins.">Methods of quantitation and identification of peptides and proteins.</a> Canadian patent CA. , (2011).</li><li>Wei&#223;, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Catch+and+measure-mass+spectrometry-based+immunoassays+in+biomarker+research.">Catch and measure-mass spectrometry-based immunoassays in biomarker research.</a> Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1844 (5), 927-932 (2014).</li><li>Nelson, A. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Antibody+fragments:+Hope+and+hype.">Antibody fragments: Hope and hype.</a> mAbs. 2 (1), 77-83 (2010).</li><li>Gupta, V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+evaluation+of+an+aptamer+for+use+as+an+affinity+reagent+with+MS:+PCSK9+as+an+example+protein.">An evaluation of an aptamer for use as an affinity reagent with MS: PCSK9 as an example protein.</a> Bioanalysis. 8 (15), 1557-1564 (2016).</li></ol>

C.H.B holds the patent on the iMALDI technology.

Compared to conventional MS-based protein quantification, iMALDI uses antibodies to enrich the analytes and purify them from complex samples, therefore making it possible to quantify proteins or peptides at low concentrations. A critical step in the iMALDI protocol is the immuno-enrichment of the target peptides. For this purpose, antibodies with high specificity and affinity should be selected. In SISCAPA, it has been reported that antibody affinities at 10-9 M or better would be needed to achieve high sensit...

Mass spectrometry has become an indispensable tool in quantitative proteomics. Mass spectrometry can determine the masses of target proteins or peptides, therefore the obtained analyte signals can be highly specific compared to immunoassays. Two ionization methods, electrospray and MALDI, are most commonly used for detecting proteins and peptides1,2,3,4. A major challenge in MS-based protein quantification lies in the detection of low-abundance proteins in complex samples at ng/mL or pg/mL concentrations in the presence of high-abundance proteins, and many candidate protein biomarkers found in human plasma are within this range5. This problem is largely caused by the inherently wide dynamic range and complexity of the human proteome6.
To overcome these detection challenges, immuno-MS methods have been developed to enrich the target proteins or peptides from the sample solutions onto a solid surface, followed by elution of the analytes and MS measurement7,8,9,10. Through immuno-enrichment, the analytes are purified from complex samples and therefore the ion-suppression effects from other molecules are minimized. Among various solid supports, magnetic beads are currently most widely used as they have the advantages of high antibody binding capacity and ease of handling. Magnetic beads with different functionalizations and sizes have been developed and commercialized for immunoprecipitation experiments. To date, immuno-enrichment on beads has been interfaced with both electrospray ionization (ESI) and MALDI-MS for protein and peptide measurement. In stable isotope standards and capture by anti-peptide antibodies (SISCAPA) technology, proteins in the samples are digested, followed by incubation with antibody-coated beads for immuno-enrichment. In &#34;classical&#34; SISCAPA, the captured proteotypic peptides are eluted from the beads, and measured by Liquid Chromatography-ESI-MS (LC-MS), or by direct infusion ESI-Multiple Reaction Monitoring-MS (ESI-MRM-MS)11,12. Immuno-enrichment improved the MRM assay sensitivity by 3-4 orders of magnitude, reaching the low ng/mL range13.
Compared to electrospray-MS, MALDI-MS is faster, and does not involve the cleaning and re-equilibration of LC columns so there are no carryover and contamination issues, making it more suitable for high-throughput studies14. Immuno-MALDI technology has been developed in our laboratory to combine immuno-enrichment with MALDI-MS for sensitive and specific quantification of peptides and proteins (based on quantitation of proteotypic peptides)15,16,17. After immuno-enrichment, the beads are deposited on a MALDI target plate, the matrix solution is added to beads, and the plate is ready for analysis by a MALDI-TOF-MS after drying. Elution of the peptides from the beads is not performed as a separate step, but affinity-bound analytes are eluted by the MALDI matrix solution when it is added to the bead spots, thereby simplifying the sample preparation and minimizing sample loss. The iMALDI technology has been applied in a variety of applications18,19, and recently has been automated and used for measuring Angiotensin I (Ang I) for determining plasma renin activity (PRA)20. This protocol will demonstrate the procedure used to perform an automated iMALDI assay. Taking the PRA assay as an example, inter-day CVs of less than 10% have been achieved through automation, with the capability of measuring 744 samples per day20.
The iMALDI PRA assay demonstrated in this manuscript does not require protein digestion, as the target molecule (Ang I) is a peptide with a molecular weight of 1295.7 Da. In other assays where protein digestion is necessary and a peptide is used as the surrogate for the intact protein, the selected peptide for iMALDI should be unique and specific to the target protein, with a mass over 800 Da so that it can be easily distinguished from the chemical noise from the MALDI matrix solution. Anti-peptide antibodies are required for the immuno-enrichment of the peptides. The protocol for an iMALDI assay measuring PRA consists of four steps: 1) generation of Ang I in human plasma; 2) immuno-enrichment of Ang I using antibody-coated beads; 3) transfer of beads to a MALDI target plate and adding matrix solution; and 4) signal acquisition by a MALDI-TOF-MS and data analysis20.

<table width="892">
	<tbody>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Healthy control human plasma</td>
			<td class="xl63" style="width:134pt" width="178">Bioreclamation</td>
			<td class="xl68" style="width:89pt" width="119">HMPLEDTA2</td>
			<td class="xl66" style="width:242pt" width="323"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Ammonium bicarbonate</td>
			<td class="xl63" style="width:134pt" width="178">Sigma Aldrich</td>
			<td class="xl69">09830</td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Ammonium citrate dibasic</td>
			<td class="xl63" style="width:134pt" width="178">Sigma Aldrich</td>
			<td class="xl68" style="width:89pt" width="119">09833</td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">CHAPS (&#62;=98%)</td>
			<td class="xl63" style="width:134pt" width="178">Sigma Aldrich</td>
			<td class="xl68" style="width:89pt" width="119">C9426</td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Albumin from chicken egg white (&#62;98%)</td>
			<td class="xl63" style="width:134pt" width="178">Sigma Aldrich</td>
			<td class="xl68" style="width:89pt" width="119">A5503</td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Ethylenediaminetetraacetic acid</td>
			<td class="xl63" style="width:134pt" width="178">Sigma Aldrich</td>
			<td class="xl68" style="width:89pt" width="119">EDS</td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Alpha-cyano-4-hydroxycinnamic acid</td>
			<td class="xl63" style="width:134pt" width="178">Sigma Aldrich</td>
			<td class="xl68" style="width:89pt" width="119">70990</td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Phosphate buffered saline</td>
			<td class="xl63" style="width:134pt" width="178">Sigma Aldrich</td>
			<td class="xl68" style="width:89pt" width="119">P4417</td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Phenylmethanesulfonyl fluoride</td>
			<td class="xl63" style="width:134pt" width="178">Sigma Aldrich</td>
			<td class="xl68" style="width:89pt" width="119">78830</td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Trifluoroacetic acid</td>
			<td class="xl63" style="width:134pt" width="178">Thermo Fisher Scientific</td>
			<td class="xl68" style="width:89pt" width="119">85172</td>
			<td class="xl66">LC-MS grade</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">acetonitrile</td>
			<td class="xl63" style="width:134pt" width="178">Fluka</td>
			<td class="xl68" style="width:89pt" width="119">34967</td>
			<td class="xl66">LC-MS grade</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">water</td>
			<td class="xl63" style="width:134pt" width="178">Fluka</td>
			<td class="xl68" style="width:89pt" width="119">39253</td>
			<td class="xl66">LC-MS grade</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">acetic acid</td>
			<td class="xl63" style="width:134pt" width="178">Fluka</td>
			<td class="xl68" style="width:89pt" width="119">320099</td>
			<td class="xl66">LC-MS grade</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Tris(hydroxymethyl)aminomethane</td>
			<td class="xl63" style="width:134pt" width="178">Roche Diagnostics</td>
			<td class="xl71">3118169001</td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Dynabeads Protein G magnetic beads</td>
			<td class="xl63" style="width:134pt" width="178">Thermo Fisher Scientific</td>
			<td class="xl68" style="width:89pt" width="119">10003D</td>
			<td class="xl66">2.8 &#956;m, 30 mg/mL</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">anti-Ang I goat polyclonal antibody</td>
			<td class="xl63" style="width:134pt" width="178">Santa Cruz Biotechnology</td>
			<td class="xl68" style="width:89pt" width="119">sc-7419</td>
			<td class="xl66"></td>
		</tr>
		<tr height="84" style="height:63.0pt">
			<td class="xl63" height="84" style="width:204pt;height:63.0pt" width="272">Nat and SIS Ang I</td>
			<td class="xl63" style="width:134pt" width="178">synthesized at the University of Victoria-Genome BC Proteomics Centre</td>
			<td class="xl68" style="width:89pt" width="119"></td>
			<td class="xl66"></td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Automated liquid handling system</td>
			<td class="xl63" style="width:134pt" width="178">Agilent</td>
			<td class="xl68" style="width:89pt" width="119">16050-102</td>
			<td class="xl66">Agilent Bravo robotic workstation</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Magnet</td>
			<td class="xl63" style="width:134pt" width="178">Thermo Fisher Scientific</td>
			<td class="xl68" style="width:89pt" width="119">12321D</td>
			<td class="xl66">Invitrogen DynaMag-2 magnet</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Tube rotator</td>
			<td class="xl63" style="width:134pt" width="178">Theromo Scientific</td>
			<td class="xl68" style="width:89pt" width="119">400110Q</td>
			<td class="xl66">Labquake Tube Rotator</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Magnet</td>
			<td class="xl63" style="width:134pt" width="178">Thermo Fisher Scientific</td>
			<td class="xl68" style="width:89pt" width="119">12027</td>
			<td class="xl66">DynaMag-96 side skirted magnet</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">Magnet</td>
			<td class="xl63" style="width:134pt" width="178">VP Scientific</td>
			<td class="xl68" style="width:89pt" width="119">771RM-1</td>
			<td class="xl66">used to pull the beads to the bottom of the well</td>
		</tr>
		<tr height="21" style="height:15.75pt">
			<td class="xl63" height="21" style="width:204pt;height:15.75pt" width="272">MALDI-TOF</td>
			<td class="xl63" style="width:134pt" width="178">Bruker</td>
			<td class="xl68" style="width:89pt" width="119"></td>
			<td class="xl66">Bruker Microflex LRF instrument</td>
		</tr>
	</tbody>
</table>

peptide and protein quantification using automated immuno-maldi (imaldi)

Mass spectrometry (MS) is one of the most commonly used technologies for quantifying proteins in complex samples, with excellent assay specificity as a result of the direct detection of the mass-to-charge ratio of each target molecule. However, MS-based proteomics, like most other analytical techniques, has a bias towards measuring high-abundance analytes, so it is challenging to achieve detection limits of low ng/mL or pg/mL in complex samples, and this is the concentration range for many disease-relevant proteins in biofluids such as human plasma. To assist in the detection of low-abundance analytes, immuno-enrichment has been integrated into the assay to concentrate and purify the analyte before MS measurement, significantly improving assay sensitivity. In this work, the immuno- Matrix-Assisted Laser Desorption/Ionization (iMALDI) technology is presented for the quantification of proteins and peptides in biofluids, based on immuno-enrichment on beads, followed by MALDI-MS measurement without prior elution. The anti-peptide antibodies are functionalized on magnetic beads, and incubated with samples. After washing, the beads are directly transferred onto a MALDI target plate, and the signals are measured by a MALDI-Time of Flight (MALDI-TOF) instrument after the matrix solution has been applied to the beads. The sample preparation procedure is simplified compared to other immuno-MS assays, and the MALDI measurement is fast. The whole sample preparation is automated with a liquid handling system, with improved assay reproducibility and higher throughput. In this article, the iMALDI assay is used for determining the peptide angiotensin I (Ang I) concentration in plasma, which is used clinically as readout of plasma renin activity for the screening of primary aldosteronism (PA).

An automated iMALDI procedure for measuring Ang I is shown in Figure 1. Target peptides (either endogenous peptides or peptides from digested proteins) are enriched on anti-peptide magnetic beads, and then the beads are transferred to a target plate for MALDI measurement. The whole procedure is simplified compared to other immuno-MS technologies that require additional peptide elution steps. Automation of the iMALDI assay allows for high-throughput analysis o...

Watch this Scientific Journal Video about Peptide and Protein Quantification Using Automated Immuno-MALDI iMALDI at JoVE.com

Peptide and Protein Quantification Using Automated Immuno-MALDI iMALDI

A protocol for the protein quantification in complex biological fluids using automated immuno-MALDI (iMALDI) technology is presented.

Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI)

Mass spectrometry (MS) is one of the most commonly used technologies for quantifying proteins in complex samples, with excellent assay specificity as a ...

The overall goal of this automated immuno-MALDI assay is to quantify peptides and intact proteins in complex biological fluids in an accurate and sensitive manner. This method can help answer key questions in the quantitative proteomics field, such as quantify protein levels for diagnostics or for monitoring a patient's response to treatment. The key advantage of this method is that it can quantify protein levels very sensitively and accurately from complex samples.This technique allows the diagnosis of diseases at an early stage because the immuno-enrichment step of the assay allows quantitation of low abundant protein and peptide biomarkers. Though this method can provide insight into plasma renin activity, it can also be applied to other disease-related studies, such as quantification of cancer-related proteins for prognosis, diagnosis, and treatment management. To begin this procedure, thaw human plasma samples in a room temperature water bath for five minutes.Then, place the samples on ice until completely thawed. Next, manually transfer 200 microliters of each plasma sample to separate wells of a 1.1 milliliter deep well plate. Centrifuge the plate for 10 minutes at two degrees Celsius and 3, 000 rpm.Then, use the Bravo to serially dilute a 500 femtomole per microliter Ang-1 NAT standard solution to prepare six calibrator solutions with chicken egg white albumin. Following centrifugation, pipette 200 microliters of each calibrator to a well and 125 microliters of generation buffer to the sample plate. Using an automated liquid handling system, mix 125 microliters of plasma supernatant or 125 microliters of the chicken egg white albumin solution with 25 microliters of angiotensin I generation buffer in a new 1.1 milliliter deep well plate.Now, automatically transfer the solutions to a 96-well plate with three replicates per solution and 34 microliters of solution per well. Then, incubate the plate at 37 degrees Celsius for three hours. For conjugation of the antibody with protein G beads, first transfer 78 microliters of previously prepared bead slurry to a 1.5 milliliter tube.Wash the beads seven times with one milliliter of 25%acetonitrile in PBSC and three times with one milliliter of PBSC, using a magnetic stand to pellet the beads between each washing. After washing the beads, resuspend them in 110 microliters of PBSC and add 110 microliters of anti-angiotensin I antibody. Mix the beads and solution by pipetting.Then, incubate the beads at room temperature for one hour while rotating at eight rpm. Following this, wash the beads three times with one milliliter of PBSC. Then, resuspend the beads in 1, 100 microliters of PBSC.Now, manually transfer the bead solution to a 96-well plate. Then, have the Bravo aliquot the beads to the same 96-well plate. After the three-hour angiotensin I generation period, place the incubation plate on ice for 10 minutes to terminate the generation of angiotensin I.Automatically dilute a stable isotope standards peptide stock solution 100-fold with PBS buffer.Further, automatically aliquot the stable isotope standard peptide dilution to a 96-well PCR plate. Transfer 10 microliters of the diluted peptide solution to each well of the incubation plate. Mix the diluted peptide solution with the plasma samples or the chicken egg white albumin solution.Automatically add the sample or standard solutions to the bead solutions to the incubation plate and mix. After incubating one hour, automatically wash the beads three times with five millimolar ammonium bicarbonate solution. Use a magnet to pull the beads to the bottom after each wash.After the last wash, add 10 microliters of the ammonium bicarbonate solution to each well to resuspend the beads. Automatically transfer seven microliters of the bead slurry onto a MALDI target plate with a spot size of 2, 600 micrometers. Once the beads have dried, automatically add two microliters of previously prepared HCCA matrix solution from the matrix well onto each sample spot on the target plate.Following this, analyze the sample spots with a MALDI-TOF instrument using positive reflector mode. Perform internal calibration, data smoothing, and baseline subtraction with the vendor-specific software. The automated iMALDI procedure for measuring angiotensin I allows for high-throughput analysis of a large number of samples with an intraday coefficient of variation below 10%Representative spectra obtained by measuring angiotensin I in human plasma samples are displayed here.Correlation of PRA values from 188 patient samples obtained with the automated iMALDI assay with PRA values obtained using a clinical LC-MS/MS procedure is shown here. The two methods have a correlation coefficient of 0.98, and the difference between the slopes may be due to the use of different internal standards or different antibodies. The linear range of the assay and the assay precision are displayed here.Once mastered, this technique can be performed in approximately five hours. While attempting this procedure, remember to properly adjust the tip head and the liquid handling speed. After this procedure, additional methods can be used to confirm primary aldosteronism in patients, including oral salt loading or saline infusion tests.The automated iMALDI technique allows the specific and accurate high-throughout quantitative screening of biological samples, including patient samples, for disease-related proteins or peptides. After watching this video, you should have a good understanding of how to perform an automate iMALDI assay for mass spectrometry-based protein and peptide quantification. Don't forget that working with biological samples, such as human plasma, is extremely hazardous, and the necessary safety precautions must always be taken while performing the procedure.

peptide-and-protein-quantification-using-automated-immuno-maldi-imaldi

Research

JoVE Journal

Chemistry

7.9K vistas.  University of Victoria-Genome BC Proteomics Centre. The overall goal of this automated immuno-MALDI assay is to quantify peptides and intact proteins in complex biological fluids in an accurate and sensitive manner. This method can help answer key questions in the quantitative proteomics field, such as quantify protein levels for diagnostics or for monitoring a patient's response to treatment. The key advantage of this method is that it can quantify protein levels very sensitively and accurately from complex samples.This technique allow...